PIK3CA H1047
|
HER2 Positive Breast Cancer
|
PIK3CA H1047
|
HER2 Positive Breast Cancer
|
trastuzumab Sensitive: B - Late Trials
|
trastuzumab Sensitive: B - Late Trials
|
PIK3CA H1047
|
CRC
|
PIK3CA H1047
|
CRC
|
selumetinib + RTB101 Sensitive: D – Preclinical
|
selumetinib + RTB101 Sensitive: D – Preclinical
|
PIK3CA H1047
|
CRC
|
PIK3CA H1047
|
CRC
|
RTB101 Sensitive: D – Preclinical
|
RTB101 Sensitive: D – Preclinical
|
PIK3CA H1047
|
CRC
|
PIK3CA H1047
|
CRC
|
selumetinib Sensitive: D – Preclinical
|
selumetinib Sensitive: D – Preclinical
|